Fortress Biotech (FBIO) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $17.00 | Feb 23, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $17.00 from $26.00 | Aug 21, 2025 |
| Roth MKM | Maintained | Buy | $16.00 from $15.00 | Mar 11, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $26.00 from $24.00 | Nov 18, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $24.00 | Jul 19, 2024 |
| Cantor Fitzgerald | Maintained | Overweight | — | Jun 20, 2024 |
| Roth MKM | Maintained | Buy | $10.00 | May 16, 2024 |
| Alliance Global Partners | Initiated Coverage | Buy | $5.00 | Mar 19, 2024 |
| Roth MKM | Maintained | Buy | $10.00 | Mar 15, 2024 |
| Roth MKM | Maintained | Buy | $15.00 from $30.00 | Nov 29, 2023 |
| Cantor Fitzgerald | Maintained | Overweight | $5.00 | Aug 15, 2023 |
| Cantor Fitzgerald | Maintained | Overweight | $5.00 from $6.00 | May 16, 2023 |
| Benchmark | Maintained | Speculative Buy | $5.00 | Apr 6, 2023 |
Frequently asked questions
Is FBIO a buy, sell, or hold?
Analysts covering Fortress Biotech currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on FBIO?
On Feb 23, 2026, HC Wainwright & Co. maintained Fortress Biotech at Buy with a price target of $17.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.